Charles Wu and Zaiguang Lu of Han Kun Law Offices review the significant legislative developments of 2022 affecting China's private equity and venture capital industry, and offer insights into the key trends, challenges and opportunities in the sector
Nathan Bush, Nicholas Klein, Catherine Pawluch, and Alexandra Kamerling of DLA Piper survey the risks under the Foreign Direct Investment regimes of key jurisdictions, starting with the U.S., Canada, and the U.K. in this two-part series
After a busy year on the capital markets, Haiping Li and Paloma Wang of Skadden Arps Slate Meagher & Flom LLP take a look at 2022's developments and what the next 12 months may hold.
Jianwei Jerry Fang, Runyang Liu and Dianmeng Zhu of Zhong Lun Law Firm discuss the year's major legislative and judicial developments in civil and commercial dispute resolution in China.
Guanglei Zhang and Jinhui Zhang of Jingtian & Gongcheng examine the first decision of a Chinese court in which a secret pre-IPO agreement containing a valuation adjustment mechanism based on stock market price was declared invalid.
Geoffrey Chan, Sophie Xue, and Nicholas Poon of Skadden, Arps, Slate, Meagher & Flom examine how the Hong Kong Limited Partnership Fund, which serves as a cost and tax efficient vehicle for private equity transactions, could become a popular alternative to traditional offshore fund structures for PE investments and fundraising in Greater China
Daisy Duan and Sara Shi of King & Wood Mallesons review newly introduced regulations supporting pre-tax deductions for enterprise innovation in science and technology in China including recommended action to take advantage of these new tax preferential policies.
Christina Lee, Wang Hang, Dr. Matthias Courvoisier and Daisy Chen of Baker McKenzie and Stella Hu of FenXun Partners highlight the requirements, framework and benefits for listing global depository receipts (GDRs) on the SIX Swiss Exchange and discuss how it differs from the London Connect.
A recent executive order issued by U.S. President Joe Biden heightened the level of scrutiny of inbound deals in certain sensitive industries. And now the U.S. is weighing legislation that calls for a "reverse CFIUS," which will add government scrutiny to outbound transactions.
In the second part of this series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices look at the ever-expanding opportunities for cooperation between insurance companies and foreign investors amidst a complex regulatory landscape
